[Interference with the activity of some dehydrogenases in intact cells of Ehrlich ascites carcinoma (EAC) as 1 of the criteria in the investigation of carcinostatic antibiotics and other drugs].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001201:Ascites; D002277:Carcinoma; D006801:Humans; D009374:Neoplasms, Experimental; D010088:Oxidoreductases / Q000737:chemistry*
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D010088:Oxidoreductases
ANTIBIOTICS/pharmacology; ANTINEOPLASTIC AGENTS/pharmacology; DEHYDROGENASES/chemistry; NEOPLASMS/experimental